- - FcγRIIIa

Christoph Gstöttner1, Steffen Lippold2, Michaela Hook3

  • 1Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.

PubMed
概括

了解抗体糖基化是治疗单克隆抗体 (mAbs) 的关键. 新的亲和染色学和电泳法揭示了糖形式差异如何影响FcγRIIIa结合,这对免疫反应至关重要.